After a promising small trial of Cortene’s new experimental drug CT38, funds are being raised for a phase 2 trial. CT38 is believed to work by effectively reducing the amount of cortisol released by the adrenal glands through upregulation of stress receptors.

Source: Cortene to Move Forward on New Drug for Chronic Fatigue Syndrome (ME/CFS) – Health Rising